(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 1. FP4mito alters Ena localization and phenocopies ena
loss-of-function. (A) FP4mito. (B-C'') S2 cells,
antigens indicated. (B) In wild-type cells (asterisk), Ena is diffusely
cytoplasmic and enriched at leading edge (arrowhead) and cell contacts (white
arrow). In FP4mito-expressing cells, GFP-FP4mito colocalizes with MitoTracker
and Ena (yellow arrow). (C) FP4mito does not recruit WASP. (D-H)
Embryonic CNS, BP102 antibody. (D) Control. (E,G) FP4mito x e22c-Gal4.
(F) ena23/enaGC1. (H)
ena210/enaGC1. Longitudinal (arrowhead) and
commissural axons (arrow). (I) ISNb motor axon projections; wild type
(left), ena mutants (right). (J-N) Projections of ISNb
(arrows, anti-Fasciclin II) in embryos expressing indicated constructs
(elav-Gal4). Scale bars: 10 µm.